Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study

被引：0
|
作者：
Koh, Adrian H. C. [1 ]
Parikh, Soumil [2 ]
机构：
[1] Camden Med Ctr, Med Retina Eye & Retina Surg, Singapore, Singapore
[2] Novartis Pharma AG, Basel, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
831
引用
收藏
页数：4
相关论文
共 50 条
  • [1] RANIBIZUMAB WITH OR WITHOUT VERTEPORFIN PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY Predictors of Visual and Anatomical Response in the EVEREST II Study
    Cheung, Chui Ming Gemmy
    Tan, Colin S.
    Patalauskaite, Ramune
    Margaron, Philippe
    Lai, Timothy Y. Y.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (02): : 387 - 392
  • [2] Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy The EVEREST II Randomized Clinical Trial
    Lim, Tock H.
    Lai, Timothy Y. Y.
    Takahashi, Kanji
    Wong, Tien Y.
    Chen, Lee-Jen
    Ruamviboonsuk, Paisan
    Tan, Colin S.
    Lee, Won Ki
    Cheung, Chui Ming Gemmy
    Ngah, Nor Fariza
    Patalauskaite, Ramune
    Margaron, Philippe
    Koh, Adrian
    JAMA OPHTHALMOLOGY, 2020, 138 (09) : 935 - 942
  • [3] LAPTOP Study: A 24-Month Trial of Verteporfin Versus Ranibizumab for Polypoidal Choroidal Vasculopathy
    Oishi, Akio
    Miyamoto, Noriko
    Mandai, Michiko
    Honda, Shigeru
    Matsuoka, Toshiyuki
    Oh, Hideyasu
    Kita, Mihori
    Nagai, Tomoko
    Bessho, Nobuhiro
    Uenishi, Mamoru
    Kurimoto, Yasuo
    Negi, Akira
    OPHTHALMOLOGY, 2014, 121 (05) : 1151 - 1152
  • [4] Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy A Randomized Clinical Trial
    Koh, Adrian
    Lai, Timothy Y. Y.
    Takahashi, Kanji
    Wong, Tien Y.
    Chen, Lee-Jen
    Ruamviboonsuk, Paisan
    Tan, Colin S.
    Feller, Chrystel
    Margaron, Philippe
    Lim, Tock H.
    Lee, Won Ki
    JAMA OPHTHALMOLOGY, 2017, 135 (11) : 1206 - 1213
  • [5] Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
    Takahashi, Kanji
    Ohji, Masahito
    Terasaki, Hiroko
    Honda, Shigeru
    Margaron, Philippe
    Guerin, Tadhg
    Yuzawa, Mitsuko
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 1789 - 1799
  • [6] EVEREST STUDY Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy
    Koh, Adrian
    Lee, Won Ki
    Chen, Lee-Jen
    Chen, Shih-Jen
    Hashad, Yehia
    Kim, Hakyoung
    Lai, Timothy Y.
    Pilz, Stefan
    Ruamviboonsuk, Paisan
    Tokaji, Erika
    Weisberger, Annemarie
    Lim, Tock H.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1453 - 1464
  • [7] Anatomical outcomes of ranibizumab 0.5 mg combined with verteporfin photodynamic therapy vs ranibizumab monotherapy in patients with polypoidal choroidal vasculopathy: 12-month results from the EVEREST II study
    Lai, Timothy Y. Y.
    Feller, Chrystel
    Margaron, Philippe
    Tan, Colin S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [8] Verteporfin PDT and Ranibizumab Combination Therapy for Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV): EVEREST Results
    Lai, T. Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [9] INTRAVITREAL RANIBIZUMAB COMBINED WITH VERTEPORFIN PHOTODYNAMIC THERAPY FOR TREATING POLYPOIDAL CHOROIDAL VASCULOPATHY
    Lee, Yeon Hee
    Lee, Eun-Kyoung
    Shin, Kyung Sup
    Lee, Kyung-Mu
    Kim, Jung Yeul
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (07): : 1287 - 1293
  • [10] The efficacy and safety of brolucizumab compared with aflibercept in polypoidal choroidal vasculopathy (PCV): 24-month results from the HAWK study
    Chang, Andrew
    Ogura, Yuichiro
    Lee, Won K.
    Cheung, Gemmy
    Jaffe, Glenn
    D'Souza, Divya
    Alam, Jahangir
    Koh, Adrian
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 149 - 149
12345